or
forgot password
  • cancer clinical trials in reading, PA

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    St. Joseph Medical Center
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Bladder Cancer
    Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    St. Joseph Medical Center
    Reading, Pennsylvania 19604
    Breast Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    St. Joseph Medical Center
    Breast Cancer
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer
    Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Leukemia
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Colorectal Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Chronic Myeloproliferative Disorders
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Colorectal Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Prostate Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Anal Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer, Radiation Toxicity
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer